These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22828174)

  • 1. Neurohypophyseal hormones protect against pentylenetetrazole-induced seizures in zebrafish: role of oxytocin-like and V1a-like receptor.
    Braida D; Donzelli A; Martucci R; Ponzoni L; Pauletti A; Sala M
    Peptides; 2012 Oct; 37(2):327-33. PubMed ID: 22828174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish.
    Braida D; Donzelli A; Martucci R; Capurro V; Busnelli M; Chini B; Sala M
    Psychopharmacology (Berl); 2012 Mar; 220(2):319-30. PubMed ID: 21956239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isosteric substitution of Asn5 in antagonists of oxytocin and vasopressin leads to highly selective and potent oxytocin and V1a receptor antagonists: new approaches for the design of potential tocolytics for preterm labor.
    Chan WY; Wo NC; Cheng LL; Manning M
    J Pharmacol Exp Ther; 1996 May; 277(2):999-1003. PubMed ID: 8627583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice.
    Boccia MM; Kopf SR; Baratti CM
    Neurobiol Learn Mem; 1998 Mar; 69(2):136-46. PubMed ID: 9619993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arg8]vasotocin excites neurones in the dorsal vagal complex in vitro: evidence for an action through novel class(es) of CNS receptors.
    Ingram CD; Tolchard S
    J Neuroendocrinol; 1994 Aug; 6(4):415-22. PubMed ID: 7987372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin.
    Stam WB; Van der Graaf PH; Saxena PR
    Br J Pharmacol; 1998 Oct; 125(4):865-73. PubMed ID: 9831926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists.
    Manning M; Cheng LL; Klis WA; Balaspiri L; Olma A; Sawyer WH; Wo NC; Chan WY
    J Med Chem; 1995 May; 38(10):1762-9. PubMed ID: 7752199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
    Fujiwara Y; Hiroyama M; Sanbe A; Yamauchi J; Tsujimoto G; Tanoue A
    J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proconvulsive effects of oxytocin in the generalized pentylenetetrazol mouse model are mediated by vasopressin 1a receptors.
    Loyens E; Vermoesen K; Schallier A; Michotte Y; Smolders I
    Brain Res; 2012 Feb; 1436():43-50. PubMed ID: 22208648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type.
    Schlosser SF; Almeida OF; Patchev VK; Yassouridis A; Elands J
    Endocrinology; 1994 Nov; 135(5):2058-63. PubMed ID: 7956927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modulatory effect of nitric oxide in pro- and anti-convulsive effects of vasopressin in PTZ-induced seizures threshold in mice.
    Javadian N; Rahimi N; Javadi-Paydar M; Doustimotlagh AH; Dehpour AR
    Epilepsy Res; 2016 Oct; 126():134-40. PubMed ID: 27497813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors.
    Yibchok-anun S; Hsu WH
    Life Sci; 1998; 63(21):1871-8. PubMed ID: 9825765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.
    Manning M; Kruszynski M; Bankowski K; Olma A; Lammek B; Cheng LL; Klis WA; Seto J; Haldar J; Sawyer WH
    J Med Chem; 1989 Feb; 32(2):382-91. PubMed ID: 2913298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors.
    Song Z; McCann KE; McNeill JK; Larkin TE; Huhman KL; Albers HE
    Psychoneuroendocrinology; 2014 Dec; 50():14-9. PubMed ID: 25173438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of arginine vasotocin vascular smooth muscle receptors in the trout (Oncorhynchus mykiss) in vitro.
    Conklin DJ; Smith MP; Olson KR
    Gen Comp Endocrinol; 1999 Apr; 114(1):36-46. PubMed ID: 10094857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.
    Andres-Mach M; Zolkowska D; Barcicka-Klosowska B; Haratym-Maj A; Florek-Luszczki M; Luszczki JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):301-9. PubMed ID: 22789660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban.
    Manning M; Cheng LL; Stoev S; Wo NC; Chan WY; Szeto HH; Durroux T; Mouillac B; Barberis C
    J Pept Sci; 2005 Oct; 11(10):593-608. PubMed ID: 15880385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.